Jon C. Ogg - Author for 24/7 Wall St.
Lastest Stories by Jon C. Ogg
The U.S. Department of Commerce reported that total retail sales posted a seasonally adjusted gain of 0.2%, but that was better than expected.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included Apple, China Mobile, Duke Energy, Facebook, JetBlue, Oracle, Spirit Airlines, TCR2 Therapeutics and Vivint Solar.
Published:
Last Updated:
24/7 Wall St. has provided a review of the top stocks in the market to show just how well some of them have done since the market V-bottom in 2009.
Published:
Last Updated:
Some reports from the U.S. Department of Labor show stronger than expected monthly payroll gains, while others do not. The case for February was the latter.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Abercrombie & Fitch, Exxon Mobil, Etsy, GameStop, Kraft Heinz, Netflix, Tilray and Vodafone.
Published:
Last Updated:
Goldman Sachs and Motif Capital have launched a joint effort to identify companies under some of the more exciting new themes influencing the future of the business culture and for people.
Published:
Last Updated:
There is a saying that nothing lasts forever, and that is what CenturyLink's management may be trying to communicate.
Published:
Last Updated:
The European Central Bank has announced that its interest rate on the main refinancing operations and the interest rates on the marginal lending facility and the deposit facility will remain...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Abercrombie & Fitch, BHP, Coca-Cola, Monster Beverage, Procter & Gamble, Rio Tinto and Toll Brothers.
Published:
Last Updated:
Micron Technology had a rough week to start off March, even if its shares are still up considerably from the start of the year.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included CSX, Intelsat, Kohl's, NIO, Rio Tinto, Teva Pharmaceutical, TripAdvisor and VMware.
Published:
Last Updated:
Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall...
Published:
Last Updated: